<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00081627</url>
  </required_header>
  <id_info>
    <org_study_id>02-CoFactor</org_study_id>
    <nct_id>NCT00081627</nct_id>
  </id_info>
  <brief_title>Clinical Trial in Patients With Metastatic Colorectal Cancer</brief_title>
  <official_title>COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mast Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mast Therapeutics, Inc.</source>
  <brief_summary>
    <textblock>
      The objectives of this trial are to determine if CoFactor in combination with 5-FU are
      effective in the treatment of metastatic colorectal cancer and to determine the side effects
      observed with the administration of CoFactor and 5-FU.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">January 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>48</enrollment>
  <condition>Colon Cancer</condition>
  <condition>Rectal Cancer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CoFactor and 5FU</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must have surgically incurable colon or rectal adenocarcinoma

          -  Karnofsky Performance Status of 60% or greater

          -  Patients may have symptomatic neuropathy

          -  Patients must have a life expectancy of at least 4 months

          -  Patients must be alimenting, receiving at least 1500Kcal/day nutrition, by any route

          -  Patients must have bidimensional measurable disease for response assessment

          -  Patients may have received adjuvant chemotherapy with fluoropyrimidine therapy

          -  Patients must have recovered from the toxicities of prior therapy, at least 4 weeks
             since prior adjuvant chemotherapy and major surgery

          -  Serum creatinine less than 2.4mg%, serum bilirubin less than 3.0mg%, WBC greater than
             3,200/mm2, AGC greater than 1,500/mm3, platelet count greater than 90,000/mm3 and SGOT
             (AST) and SGPT (ALT) less than 3 times the upper limit of normal

          -  Male and non-pregnant, non-lactating female patients must be &gt;18 years old.

        Exclusion Criteria:

          -  Concurrent infection

          -  Failure of the patient or the patient's legal representative to sign the Informed
             consent

          -  Inability to obtain Informed Consent because of psychiatric or complex medical problem

          -  Patients with unstable oncologic emergency

          -  Patients with unstable medical conditions such as angina, transient ischemic attacks,
             rising creatinine, accelerated hypertension, etc.

          -  Cerebellar neurologic syndromes such as Parkinson's Disease, multiple sclerosis and
             amyotonia

          -  Known intolerance to fluoropyrimidine therapy suggestive of dihydropyrimidine
             dehydrogenase deficiency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tony Reid, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSD Moores Cancer Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA San Diego Healthcare System</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Killeen Cancer Center</name>
      <address>
        <city>Killeen</city>
        <state>Texas</state>
        <zip>76549</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHC Bezanijska Kosa</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Former Serbia and Montenegro</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Former Serbia and Montenegro</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Oncology and Radiology Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Former Serbia and Montenegro</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Oncology</name>
      <address>
        <city>Sremska Kamenica</city>
        <zip>21204</zip>
        <country>Former Serbia and Montenegro</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Former Serbia and Montenegro</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2004</study_first_submitted>
  <study_first_submitted_qc>October 13, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2004</study_first_posted>
  <last_update_submitted>November 26, 2007</last_update_submitted>
  <last_update_submitted_qc>November 26, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2007</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

